Antibiotics are effective therapy for Crohn's disease

Inflammatory Bowel Diseases

Volumn 3, Issue 4, 1997, Pages 318-319

  Peppercorn, Mark A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000242938     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1002/ibd.3780030411     Document Type: Article

References (19)

1. Brandt LJ, Bernstein LH, Boley SJ, Frank MS. Metronidazole therapy for perineal Crohn's disease: a follow-up study. Gastroenterology 1982;83:383-7.
2. Turunen U, Farkkila V, Valtonen V, Seppala X. Long-term outcome of ciprofloxacin treatment in severe perianal or fistulous Crohn's disease. Gastroenterology 1993;104:A793.
3. Moss AA, Carbone JV, Kressel HY. Radiologic and clinical assessment of broad spectrum antibiotic therapy in Crohn's disease. AJR 1978;131:787-90.
4. Peppercorn MA. Is there a role for antibiotics as primary therapy in Crohn's ileitis? J Clin Gastroenterol 1993;17:235-7.
5. Rubin PH, Chapman ML, Scherl E, Sachar DB, Stamaty C, Present DH. Clarithromycin in active Crohn's disease: preliminary results of open-label pilot study. Gastroenterology 1996;110:A1005.
6. Greenbloom SL, Steinhart AH, Greenberg GR. Ciprofloxacin and metronidazole combination antibiotic therapy for ileocolonic Crohn's disease. Gastroenterology 1995;108:A827.
7. Saverymutter S, Hodgson HJF, Chadwick VS. Controlled trial comparing prednisone with an elemental diet plus nonabsorbable antibiotics in active Crohn's disease. Gut 1985;26:994-8.
8. Ursing B, Alm T, Barany F, et al. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. Gastroenterology 1982;83: 550-62.
9. Sutherland LR, Singleton J, Sessions J, et al. Double-blind placebo-controlled trial of metronidazole in Crohn's disease. Gut 1991;32:1071-5.
10. Ambrose NS, Allan RN, Keighley MR, et al. Antibiotic therapy for treatment in relapse of intestinal Crohn's disease. Dis Colon Rectum 1985;28:81-5.
11. Prantera C, Zannoni F, Scribano ML, et al. An antibiotic regimen for the treatment of active Crohn's disease: a randomized controlled clinical trial of metronidazole plus ciprofloxacin. Am J Gastroenterol 1996;91:328-32.
12. Colombel JF, Lemann M, Cassagnon M, et al., and GETAID. A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Gastroenterology 1997;112: A951.
13. Graham DY, Al-Assi MY, Robinson M. Prolonged remission in Crohn's disease following therapy for Mycobacterium paratuberculosis infection. Gastroenterology 1995;108:A826.
14. Rutgeerts P, Goboes K, Peeters M, et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 1991;338:771-4.
15. Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995;108:1617-21.
16. Sartor RB. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. In: Peppercorn MA, ed. Gastroenterology clinics of North America. Philadelphia: Sanders, 1995:475-507.
17. Rasmussen SN, Lauritsen K, Tage-Jensen U, et al. 5-Aminosalicylic acid in the treatment of Crohn's disease. A 16 week double-blind placebo-controlled multicenter study of Pentasa. Scand J Gastroenterol 1987;22:877-83.
18. Singleton J. Second trial of mesalamine therapy in the treatment of active Crohn's disease. Gastroenterology 1994;107:632-3.
19. Singleton JW, Summers RW, Kern F. A trial of sulfasalazine as adjunctive therapy in Crohn's disease. Gastroenterology 1979;77: 887-97.